Autolus Therapeutics plc (“Autolus”) announced on 6/22/2018 the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530... read more
Autolus Therapeutics plc (“Autolus”) announced on 6/22/2018 the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530... read more
Phelps Hospital has launched Dascena’s InSight algorithm house wide. InSight is a machine learning platform built for accurate sepsis onset predictions using only vital signs in the hospital’s EHR... read more
Servier and Taiho Pharmaceutical Co., Ltd. Announced on 6/21/2-18 clinical data from the pivotal Phase III trial (TAGS) for Lonsurf (trifluridine and tipiracil, TAS-102) which showed... read more
... read more
The vast majority of the laws are directed towards pharmacy benefits managers (PBMs). Most prohibit PBMs from placing limits on... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,